Status:
COMPLETED
Selenium in the Treatment of Arsenic Toxicity and Cancers
Lead Sponsor:
Texas Tech University
Collaborating Sponsors:
National Cancer Institute (NCI)
American Cancer Society, Inc.
Conditions:
Arsenical Melanosis
Arsenical Keratosis
Eligibility:
All Genders
12-55 years
Phase:
PHASE3
Brief Summary
Context: Approximately 100 million people throughout the world consume water contaminated with arsenic at levels above carcinogenic thresholds, including 40 million in Bangladesh alone, with up to one...
Eligibility Criteria
Inclusion
- Resident of Bangladesh in an arsenic-affected region (Chandpur)
- Age between 12 and 55
- Exposure to arsenic in home drinking water greater than 50 ug/L.
- Arsenical melanosis on the torso confirmed by epiluminescence microscopy
Exclusion
- Recent history or plans to consume selenium-containing supplements
- Anticipated change in home drinking water supply during study period
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
819 Patients enrolled
Trial Details
Trial ID
NCT01442727
Start Date
December 1 2006
End Date
April 1 2009
Last Update
October 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SETAC Trial Field Office
Kalibari Town, Chandpur District, Bangladesh